JENNY FU: Open Payments
NPI 1679944573 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 10 payments from 7 companies in 2025. Trend: 2023 $2,655 · 2024 $1,707 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $168 |
| JAZZ PHARMACEUTICALS INC. | 1 | $150 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Deciphera Pharmaceuticals Inc. | 2 | $47 |
| Daiichi Sankyo Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $16 |
Products named: ZEPZELCA, AUSTEDO XR, OJJAARA, QINLOCK, IMFINZI, DATROWAY.
Industry payments across CA — which companies pay providers there.
